| Analysis | Samples | Factors | Units |
|---|---|---|---|
| NMR data | CD_A549_3_1_IPI3_rep1 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:Ipilimumab | nanomoles |
| NMR data | CD_A549_3_1_IPI3_rep2 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:Ipilimumab | nanomoles |
| NMR data | CD_A549_3_1_IPI3_rep3 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:Ipilimumab | nanomoles |
| NMR data | CD_A549_3_1_NIV3_rep1 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:Nivolumab | nanomoles |
| NMR data | CD_A549_3_1_NIV3_rep3 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:Nivolumab | nanomoles |
| NMR data | CD_A549_TW_NIV2_rep2 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:Nivolumab | nanomoles |
| NMR data | CD_A549_3_1_CTL3_rep1 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:No treatment | nanomoles |
| NMR data | CD_A549_3_1_CTL3_rep3 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:No treatment | nanomoles |
| NMR data | CD_A549_TW_CTL2_rep2 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:No treatment | nanomoles |
| NMR data | CD_A549_TW_IPI3_rep1 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:Ipilimumab | nanomoles |
| NMR data | CD_A549_TW_IPI3_rep2 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:Ipilimumab | nanomoles |
| NMR data | CD_A549_TW_IPI3_rep3 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:Ipilimumab | nanomoles |
| NMR data | CD_A549_NIV2_rep2 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:Nivolumab | nanomoles |
| NMR data | CD_A549_TW_NIV3_rep1 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:Nivolumab | nanomoles |
| NMR data | CD_A549_TW_NIV3_rep3 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:Nivolumab | nanomoles |
| NMR data | CD_A549_CTL2_rep2 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:No treatment | nanomoles |
| NMR data | CD_A549_TW_CTL3_rep1 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:No treatment | nanomoles |
| NMR data | CD_A549_TW_CTL3_rep3 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:No treatment | nanomoles |
| NMR data | CD_A549_IPI3_rep1 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Monoculture | Immune checkpoint inhibitor:Ipilimumab | nanomoles |
| NMR data | CD_A549_IPI3_rep2 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Monoculture | Immune checkpoint inhibitor:Ipilimumab | nanomoles |
| NMR data | CD_A549_IPI3_rep3 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Monoculture | Immune checkpoint inhibitor:Ipilimumab | nanomoles |
| NMR data | CD_A549_3_1_NIV2_rep2 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Monoculture | Immune checkpoint inhibitor:Nivolumab | nanomoles |
| NMR data | CD_A549_NIV3_rep1 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Monoculture | Immune checkpoint inhibitor:Nivolumab | nanomoles |
| NMR data | CD_A549_NIV3_rep3 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Monoculture | Immune checkpoint inhibitor:Nivolumab | nanomoles |
| NMR data | CD_A549_3_1_CTL2_rep2 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Monoculture | Immune checkpoint inhibitor:No treatment | nanomoles |
| NMR data | CD_A549_CTL3_rep1 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Monoculture | Immune checkpoint inhibitor:No treatment | nanomoles |
| NMR data | CD_A549_CTL3_rep3 | Sample source:Non-small cell lung cancer cells | Cell line:A549 | Culture Type:Monoculture | Immune checkpoint inhibitor:No treatment | nanomoles |
| NMR data | CD_H292_TW_IPI1_rep1 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:Ipilimumab | nanomoles |
| NMR data | CD_H292_TW_IPI1_rep2 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:Ipilimumab | nanomoles |
| NMR data | CD_H292_TW_IPI1_rep3 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:Ipilimumab | nanomoles |
| NMR data | CD_H292_TW_NIV1_rep1 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:Nivolumab | nanomoles |
| NMR data | CD_H292_TW_NIV1_rep2 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:Nivolumab | nanomoles |
| NMR data | CD_H292_TW_NIV1_rep3 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:Nivolumab | nanomoles |
| NMR data | CD_H292_TW_CTL1_rep1 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:No treatment | nanomoles |
| NMR data | CD_H292_TW_CTL1_rep2 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:No treatment | nanomoles |
| NMR data | CD_H292_TW_CTL1_rep3 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:No treatment | nanomoles |
| NMR data | CD_H292_IPI1_rep1 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:Ipilimumab | nanomoles |
| NMR data | CD_H292_IPI1_rep2 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:Ipilimumab | nanomoles |
| NMR data | CD_H292_IPI1_rep3 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:Ipilimumab | nanomoles |
| NMR data | CD_H292_NIV1_rep1 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:Nivolumab | nanomoles |
| NMR data | CD_H292_NIV1_rep2 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:Nivolumab | nanomoles |
| NMR data | CD_H292_NIV1_rep3 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:Nivolumab | nanomoles |
| NMR data | CD_H292_CTL1_rep1 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:No treatment | nanomoles |
| NMR data | CD_H292_CTL1_rep2 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:No treatment | nanomoles |
| NMR data | CD_H292_CTL1_rep3 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:No treatment | nanomoles |
| NMR data | CD_H292_3_1_IPI1_rep1 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Monoculture | Immune checkpoint inhibitor:Ipilimumab | nanomoles |
| NMR data | CD_H292_3_1_IPI1_rep2 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Monoculture | Immune checkpoint inhibitor:Ipilimumab | nanomoles |
| NMR data | CD_H292_3_1_IPI1_rep3 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Monoculture | Immune checkpoint inhibitor:Ipilimumab | nanomoles |
| NMR data | CD_H292_3_1_NIV1_rep1 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Monoculture | Immune checkpoint inhibitor:Nivolumab | nanomoles |
| NMR data | CD_H292_3_1_NIV1_rep2 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Monoculture | Immune checkpoint inhibitor:Nivolumab | nanomoles |
| NMR data | CD_H292_3_1_NIV1_rep3 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Monoculture | Immune checkpoint inhibitor:Nivolumab | nanomoles |
| NMR data | CD_H292_3_1_CTL1_rep1 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Monoculture | Immune checkpoint inhibitor:No treatment | nanomoles |
| NMR data | CD_H292_3_1_CTL1_rep2 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Monoculture | Immune checkpoint inhibitor:No treatment | nanomoles |
| NMR data | CD_H292_3_1_CTL1_rep3 | Sample source:Non-small cell lung cancer cells | Cell line:H292 | Culture Type:Monoculture | Immune checkpoint inhibitor:No treatment | nanomoles |
| NMR data | CD_PC9_3_1_IPI1_rep1 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:Ipilimumab | nanomoles |
| NMR data | CD_PC9_3_1_IPI1_rep2 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:Ipilimumab | nanomoles |
| NMR data | CD_PC9_3_1_IPI1_rep3 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:Ipilimumab | nanomoles |
| NMR data | CD_PC9_NIV1_rep1 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:Nivolumab | nanomoles |
| NMR data | CD_PC9_NIV1_rep2 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:Nivolumab | nanomoles |
| NMR data | CD_PC9_NIV1_rep3 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:Nivolumab | nanomoles |
| NMR data | CD_PC9_CTL1_rep1 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:No treatment | nanomoles |
| NMR data | CD_PC9_CTL1_rep2 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:No treatment | nanomoles |
| NMR data | CD_PC9_CTL1_rep3 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Direct Co-culture | Immune checkpoint inhibitor:No treatment | nanomoles |
| NMR data | CD_PC9_TW_IPI1_rep1 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:Ipilimumab | nanomoles |
| NMR data | CD_PC9_TW_IPI1_rep2 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:Ipilimumab | nanomoles |
| NMR data | CD_PC9_TW_IPI1_rep3 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:Ipilimumab | nanomoles |
| NMR data | CD_PC9_TW_NIV1_rep1 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:Nivolumab | nanomoles |
| NMR data | CD_PC9_TW_NIV1_rep2 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:Nivolumab | nanomoles |
| NMR data | CD_PC9_TW_NIV1_rep3 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:Nivolumab | nanomoles |
| NMR data | CD_PC9_TW_CTL1_rep1 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:No treatment | nanomoles |
| NMR data | CD_PC9_TW_CTL3_rep | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:No treatment | nanomoles |
| NMR data | CD_PC9_TW_CTL3_rep3 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Indirect Co-culture | Immune checkpoint inhibitor:No treatment | nanomoles |
| NMR data | CD_PC9_IPI3_rep1 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Monoculture | Immune checkpoint inhibitor:Ipilimumab | nanomoles |
| NMR data | CD_PC9_IPI3_rep2 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Monoculture | Immune checkpoint inhibitor:Ipilimumab | nanomoles |
| NMR data | CD_PC9_IPI3_rep3 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Monoculture | Immune checkpoint inhibitor:Ipilimumab | nanomoles |
| NMR data | CD_PC9_3_1_NIV1_rep1 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Monoculture | Immune checkpoint inhibitor:Nivolumab | nanomoles |
| NMR data | CD_PC9_3_1_NIV1_rep2 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Monoculture | Immune checkpoint inhibitor:Nivolumab | nanomoles |
| NMR data | CD_PC9_3_1_NIV1_rep3 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Monoculture | Immune checkpoint inhibitor:Nivolumab | nanomoles |
| NMR data | CD_PC9_3_1_CTL1_rep1 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Monoculture | Immune checkpoint inhibitor:No treatment | nanomoles |
| NMR data | CD_PC9_3_1_CTL1_rep2 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Monoculture | Immune checkpoint inhibitor:No treatment | nanomoles |
| NMR data | CD_PC9_3_1_CTL1_rep3 | Sample source:Non-small cell lung cancer cells | Cell line:PC-9 | Culture Type:Monoculture | Immune checkpoint inhibitor:No treatment | nanomoles |
Return to study ST003286 main page
Download data matrix(Interaction between NSCLC cells, CD8+ T cells and immune checkpoint inhibitors potentiates coagulation and promotes metabolic remodeling- new cues on CAT-VTE NMR data)
- Metabolomics Workbench
|